Serum Metabolomics in PCOS Women with Different Body Mass Index
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder, affecting 5–10% of women of reproductive age. It results from complex environmental factors, genetic predisposition, hyperinsulinemia, hormonal imbalance, neuroendocrine abnormalities, chronic inflammation, and...
Main Authors: | Katarzyna Ożegowska, Szymon Plewa, Urszula Mantaj, Leszek Pawelczyk, Jan Matysiak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/13/2811 |
Similar Items
-
Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
by: Katarzyna Ozegowska, et al.
Published: (2020-12-01) -
How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics
by: Xiaoxuan Zhao, et al.
Published: (2021-06-01) -
Detection of Type 2 Diabetes Mellitus in Serum from Women with Polycystic Ovarian Syndrome
by: Baghdad Science Journal
Published: (2013-06-01) -
Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis
by: Poli Mara Spritzer, et al.
Published: (2021-02-01) -
Metabolic inflexibility in women with PCOS is similar to women with type 2 diabetes
by: Nicholas T. Broskey, et al.
Published: (2018-10-01)